Dmoszynska A, Kloczko J, Rokicka M, Hellmann A, Spicka I, Eid JE. A dose exploration, phase I/II study of administration of continuous erythropoietin receptor activator once every 3 weeks in anemic patients with multiple myeloma receiving chemotherapy. Haematologica [Internet]. 2007Apr.1 [cited 2026Nov.5];92(4):493-01. Available from: https://haematologica.org/article/view/4401